Product Information

CLINDAMYC-BNZ PEROX 1.2-3.75% is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $2.4723 per GM under NDC 51672140304. Its NADAC has been published 136 times since Jan 17, 2024.

FDA first approved this application on Jun 5, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLINDAMYC-BNZ PEROX 1.2-3.75%

Clindamycin Phosphate and Benzoyl Peroxide
$2.4723per GM

Strength

50; 10 mg/g; mg/g

NDC

51672140304

Classification

Generic

Dosage Form

GEL

Route

TOPICAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA208683

FDA Approved

6/5/2018

TE Code

AB

On Market Since

6/5/2018

Pharmacological Classes

Decreased Sebaceous Gland Activity
Lincosamide Antibacterial
Lincosamides
Neuromuscular Blockade

Price Statistics

The NADAC for CLINDAMYC-BNZ PEROX 1.2-3.75% has been published 136 times since Jan 17, 2024, and over the history we have for it it has declined 59.3%. The table below summarizes its recorded NADAC range and movement.

Current price$2.4723 per GM
All-time high$7.6354 (Apr 10, 2024)
All-time low$2.3828 (Jun 17, 2026)
52-week high$4.6087
52-week low$2.3828
Median price$4.5237
Average price$4.4037
Largest weekly change-45.1% (Apr 17, 2024)
Weeks tracked136
Tracking sinceJan 17, 2024

Price History

1W

+0.2%

1M

+0.2%

3M

+1.0%

6M

-39.6%

1Y

-34.4%

3Y

N/A

5Y

N/A

All

-59.3%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 84% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CLINDAMYC-BNZ PEROX 1.2-3.75%?

The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYC-BNZ PEROX 1.2-3.75%, manufactured by Sun Pharmaceutical Industries Inc., is $2.4723 per GM (NDC 51672140304), effective Aug 19, 2026.

How has the price of CLINDAMYC-BNZ PEROX 1.2-3.75% changed over time?

Over the history we have for it, the NADAC for CLINDAMYC-BNZ PEROX 1.2-3.75% has declined 59.3%. It has been tracked across 136 weekly CMS publications since Jan 17, 2024.

What are the highest and lowest recorded NADAC prices for CLINDAMYC-BNZ PEROX 1.2-3.75%?

Since Jan 17, 2024, the NADAC for CLINDAMYC-BNZ PEROX 1.2-3.75% has ranged from a low of $2.3828 (Jun 17, 2026) to a high of $7.6354 (Apr 10, 2024), with a median of $4.5237 per GM.

Are there cheaper alternatives to CLINDAMYC-BNZ PEROX 1.2-3.75%?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLIND PH-BENZOYL PEROX 1.2-5%, is $0.3993 per GM — about 84% below CLINDAMYC-BNZ PEROX 1.2-3.75%.

Who manufactures CLINDAMYC-BNZ PEROX 1.2-3.75%?

CLINDAMYC-BNZ PEROX 1.2-3.75% (NDC 51672140304) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.